We are driven by the passion to nurture and preserve the precious moments of everyday life for all people, regardless of their health condition. From treatment to disease prevention, we will continue to develop innovative new drugs that contribute to better health and bring smiles to the faces of people everywhere.
Latest News
-
March 17, 2025
News Releases
Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech（PDF：236.3 KB）
-
February 26, 2025
News Releases
Solar Power Generation Facility Launched at Taiho Pharmaceutical's Kitajima Plant to Accelerate Carbon Neutrality Initiatives（PDF：375.5 KB）
-
February 14, 2025
Information
Otsuka Holdings announces FY2024 financial results
-
February 07, 2025
News Releases
Otsuka Group Selected for CDP Climate Change A List for a Third Consecutive Year
-
January 29, 2025
News Releases
Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy（PDF：180.4 KB）
MOVIE
TAIHO PHARMA STORY
Introducing Taiho Pharmaceutical’s history and its unique approaches in R&D.
This video is not intended to constitute promotion or advertisement of any products.